Literature DB >> 26866722

Tatton-Brown-Rahman syndrome due to 2p23 microdeletion.

Nobuhiko Okamoto1, Yasuhisa Toribe2, Keiko Shimojima3, Toshiyuki Yamamoto3.   

Abstract

Tatton-Brown-Rahman syndrome is a new overgrowth syndrome due to DNMT3A (DNA cytosine 5 methyltransferase 3A) mutations. Mutation carriers show a distinctive facial appearance, intellectual disability, and increased height. We report a patient with overgrowth who showed submicroscopic deletion of chromosome 2p23 including DNMT3A. The deletion was detected by array-CGH. He showed moderate ID and distinctive facial gestalt. His clinical features were consistent with those of Tatton-Brown-Rahman syndrome. We suggest that 2p23 microdeletion including DNMT3A may cause similar symptoms in patients with DNMT3A mutations and should be considered in patients with overgrowth.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  DNMT3A; Tatton-Brown-Rahman syndrome; overgrowth syndrome

Mesh:

Substances:

Year:  2016        PMID: 26866722     DOI: 10.1002/ajmg.a.37588

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  11 in total

Review 1.  Epigenetic Mistakes in Neurodevelopmental Disorders.

Authors:  Giuseppina Mastrototaro; Mattia Zaghi; Alessandro Sessa
Journal:  J Mol Neurosci       Date:  2017-03-02       Impact factor: 3.444

2.  PTRHD1 (C2orf79) mutations lead to autosomal-recessive intellectual disability and parkinsonism.

Authors:  Hamidreza Khodadadi; Luis J Azcona; Vajiheh Aghamollaii; Mir Davood Omrani; Masoud Garshasbi; Shaghayegh Taghavi; Abbas Tafakhori; Gholam Ali Shahidi; Javad Jamshidi; Hossein Darvish; Coro Paisán-Ruiz
Journal:  Mov Disord       Date:  2016-10-18       Impact factor: 10.338

Review 3.  [Tatton-Brown-Rahman syndrome associated with the DNMT3A gene: a case report and literature review].

Authors:  Min Chen; Si-Tao Li; Yao Cai; Xin Xiao; Cong-Cong Shi; Hu Hao
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-10

4.  Further delineation of neuropsychiatric findings in Tatton-Brown-Rahman syndrome due to disease-causing variants in DNMT3A: seven new patients.

Authors:  Jair Tenorio; Pablo Alarcón; Pedro Arias; Irene Dapía; Sixto García-Miñaur; María Palomares Bralo; Jaume Campistol; Salvador Climent; Irene Valenzuela; Sergio Ramos; Antonio Martínez Monseny; Fermina López Grondona; Javier Botet; Mercedes Serrano; Mario Solís; Fernando Santos-Simarro; Sara Álvarez; Gisela Teixidó-Tura; Alberto Fernández Jaén; Gema Gordo; María Belén Bardón Rivera; Julián Nevado; Alicia Hernández; Juan C Cigudosa; Víctor L Ruiz-Pérez; Eduardo F Tizzano; Pablo Lapunzina
Journal:  Eur J Hum Genet       Date:  2019-11-04       Impact factor: 4.246

5.  Co-occurrence of a maternally inherited DNMT3A duplication and a paternally inherited pathogenic variant in EZH2 in a child with growth retardation and severe short stature: atypical Weaver syndrome or evidence of a DNMT3A dosage effect?

Authors:  Katarzyna Polonis; Patrick R Blackburn; Raul A Urrutia; Gwen A Lomberk; Teresa Kruisselbrink; Margot A Cousin; Nicole J Boczek; Nicole L Hoppman; Dusica Babovic-Vuksanovic; Eric W Klee; Pavel N Pichurin
Journal:  Cold Spring Harb Mol Case Stud       Date:  2018-08-01

Review 6.  Effect of Disease-Associated Germline Mutations on Structure Function Relationship of DNA Methyltransferases.

Authors:  Allison B Norvil; Debapriya Saha; Mohd Saleem Dar; Humaira Gowher
Journal:  Genes (Basel)       Date:  2019-05-14       Impact factor: 4.096

7.  Gain-of-function DNMT3A mutations cause microcephalic dwarfism and hypermethylation of Polycomb-regulated regions.

Authors:  Patricia Heyn; Clare V Logan; Adeline Fluteau; Rachel C Challis; Tatsiana Auchynnikava; Carol-Anne Martin; Joseph A Marsh; Francesca Taglini; Fiona Kilanowski; David A Parry; Valerie Cormier-Daire; Chin-To Fong; Kate Gibson; Vivian Hwa; Lourdes Ibáñez; Stephen P Robertson; Giorgia Sebastiani; Juri Rappsilber; Robin C Allshire; Martin A M Reijns; Andrew Dauber; Duncan Sproul; Andrew P Jackson
Journal:  Nat Genet       Date:  2018-11-26       Impact factor: 38.330

8.  Growth disrupting mutations in epigenetic regulatory molecules are associated with abnormalities of epigenetic aging.

Authors:  Aaron R Jeffries; Reza Maroofian; Claire G Salter; Barry A Chioza; Harold E Cross; Michael A Patton; Emma Dempster; I Karen Temple; Deborah J G Mackay; Faisal I Rezwan; Lise Aksglaede; Diana Baralle; Tabib Dabir; Matthew F Hunter; Arveen Kamath; Ajith Kumar; Ruth Newbury-Ecob; Angelo Selicorni; Amanda Springer; Lionel Van Maldergem; Vinod Varghese; Naomi Yachelevich; Katrina Tatton-Brown; Jonathan Mill; Andrew H Crosby; Emma L Baple
Journal:  Genome Res       Date:  2019-06-03       Impact factor: 9.043

Review 9.  PRC2 functions in development and congenital disorders.

Authors:  Orla Deevy; Adrian P Bracken
Journal:  Development       Date:  2019-10-01       Impact factor: 6.868

10.  The Tatton-Brown-Rahman Syndrome: A clinical study of 55 individuals with de novo constitutive DNMT3A variants.

Authors:  Katrina Tatton-Brown; Anna Zachariou; Chey Loveday; Anthony Renwick; Shazia Mahamdallie; Lise Aksglaede; Diana Baralle; Daniela Barge-Schaapveld; Moira Blyth; Mieke Bouma; Jeroen Breckpot; Beau Crabb; Tabib Dabir; Valerie Cormier-Daire; Christine Fauth; Richard Fisher; Blanca Gener; David Goudie; Tessa Homfray; Matthew Hunter; Agnete Jorgensen; Sarina G Kant; Cathy Kirally-Borri; David Koolen; Ajith Kumar; Anatalia Labilloy; Melissa Lees; Carlo Marcelis; Catherine Mercer; Cyril Mignot; Kathryn Miller; Katherine Neas; Ruth Newbury-Ecob; Daniela T Pilz; Renata Posmyk; Carlos Prada; Keri Ramsey; Linda M Randolph; Angelo Selicorni; Deborah Shears; Mohnish Suri; I Karen Temple; Peter Turnpenny; Lionel Val Maldergem; Vinod Varghese; Hermine E Veenstra-Knol; Naomi Yachelevich; Laura Yates; Nazneen Rahman
Journal:  Wellcome Open Res       Date:  2018-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.